{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:50:19Z","timestamp":1777625419222,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["ID 7204"],"award-info":[{"award-number":["ID 7204"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["7520"],"award-info":[{"award-number":["7520"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["ID 5174 -"],"award-info":[{"award-number":["ID 5174 -"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["120356933205"],"award-info":[{"award-number":["120356933205"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["120356933427"],"award-info":[{"award-number":["120356933427"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["ID 5170"],"award-info":[{"award-number":["ID 5170"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.xphs.2019.03.034","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T14:06:59Z","timestamp":1554473219000},"page":"2534-2541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment"],"prefix":"10.1016","volume":"108","author":[{"given":"Alexander","family":"Rodr\u00edguez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa N.","family":"Pimentel-Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela J.","family":"Espejo-Mojica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"Van Hecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Tiels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Callewaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos J.","family":"Alm\u00e9ciga-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2019.03.034_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"11","key":"10.1016\/j.xphs.2019.03.034_bib2","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1007\/s11033-014-3383-3","article-title":"Computational analysis of human N-acetylgalactosamine-6-sulfate sulfatase enzyme: an update in genotype-phenotype correlation for Morquio A","volume":"41","author":"Olarte-Avellaneda","year":"2014","journal-title":"Mol Biol Rep"},{"issue":"9","key":"10.1016\/j.xphs.2019.03.034_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/21678707.2016.1214572","article-title":"Current therapies for Morquio A syndrome and their clinical outcomes","volume":"4","author":"Sawamoto","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.034_bib4","first-page":"65","article-title":"Current and emerging treatments and surgical interventions for Morquio A syndrome: a review","volume":"2012","author":"Tomatsu","year":"2012","journal-title":"Res Rep Endocr Disord"},{"issue":"6","key":"10.1016\/j.xphs.2019.03.034_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40265-014-0210-z","article-title":"Elosulfase alfa: first global approval","volume":"74","author":"Sanford","year":"2014","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.xphs.2019.03.034_bib6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"17","author":"Tomatsu","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.xphs.2019.03.034_bib7","doi-asserted-by":"crossref","first-page":"e12194","DOI":"10.1371\/journal.pone.0012194","article-title":"Enzyme replacement in a human model of mucopolysaccharidosis IVA in\u00a0vitro and its biodistribution in the cartilage of wild type mice","volume":"5","author":"Dvorak-Ewell","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.xphs.2019.03.034_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/mt.2010.32","article-title":"Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome","volume":"18","author":"Tomatsu","year":"2010","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.xphs.2019.03.034_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.034_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2014.08.012","article-title":"Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial","volume":"114","author":"Hendriksz","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"20","key":"10.1016\/j.xphs.2019.03.034_bib11","doi-asserted-by":"crossref","DOI":"10.3310\/hta10200","article-title":"A\u00a0systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1","volume":"10","author":"Connock","year":"2006","journal-title":"Health Technol Assess"},{"issue":"18","key":"10.1016\/j.xphs.2019.03.034_bib12","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2165\/00003495-200767180-00005","article-title":"Treatment of lysosomal storage disorders: progress with enzyme replacement therapy","volume":"67","author":"Rohrbach","year":"2007","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.xphs.2019.03.034_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.clinthera.2014.11.005","article-title":"Immunogenicity of elosulfase alfa, an enzyme replacement therapy in patients with Morquio a syndrome: results from MOR-004, a phase III trial","volume":"37","author":"Schweighardt","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.xphs.2019.03.034_bib14","series-title":"Mucopolysaccharidoses Update (2 Volume Set)","first-page":"235","article-title":"Mucopolysaccharidosis type IVA: clinical features, biochemistry, diagnosis, genetics, and treatment","author":"Sawamoto","year":"2018"},{"key":"10.1016\/j.xphs.2019.03.034_bib15","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/DDDT.S68562","article-title":"Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome","volume":"9","author":"Tomatsu","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.034_bib16","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.ymgme.2012.11.082","article-title":"Production of human recombinant alpha-N-acetylglucosaminidase enzymes in two Pichia pastoris strains","volume":"108","author":"Espejo-Mojica","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.xphs.2019.03.034_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbiotec.2016.03.031","article-title":"Production and characterization of recombinant human acid alpha-glucosidase in transgenic rice cell suspension culture","volume":"226","author":"Jung","year":"2016","journal-title":"J\u00a0Biotechnol"},{"issue":"16","key":"10.1016\/j.xphs.2019.03.034_bib18","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40265-015-0479-6","article-title":"Sebelipase alfa: first global approval","volume":"75","author":"Shirley","year":"2015","journal-title":"Drugs"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.03.034_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2015.06.001","article-title":"Human recombinant lysosomal enzymes produced in microorganisms","volume":"116","author":"Espejo-Mojica","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.xphs.2019.03.034_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bab.1660","article-title":"Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris","volume":"65","author":"Pimentel","year":"2018","journal-title":"Biotechnol Appl Biochem"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.034_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00253-007-1209-0","article-title":"Yeast expression platforms","volume":"77","author":"Boer","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"issue":"12","key":"10.1016\/j.xphs.2019.03.034_bib22","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.procbio.2012.07.028","article-title":"Characterization of a recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in E. coli for enzyme replacement therapy of Morquio A disease","volume":"47","author":"Mosquera","year":"2012","journal-title":"Process Biochem"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.034_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2217\/fmb.14.104","article-title":"Engineering yeast for producing human glycoproteins: where are we now?","volume":"10","author":"Laukens","year":"2015","journal-title":"Future Microbiol"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.034_bib24","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ymgme.2013.12.083","article-title":"Human lysosomal \u03b2-N-acetylglucosaminidases produced in Pichia pastoris GS115: a feasible source for enzyme replacement therapy","volume":"111","author":"Espejo-Mojica","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.034_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1006\/prep.2000.1325","article-title":"Expression and characterization of glycosylated and catalytically active recombinant human alpha-galactosidase A produced in Pichia pastoris","volume":"20","author":"Chen","year":"2000","journal-title":"Protein Expr Purif"},{"issue":"6","key":"10.1016\/j.xphs.2019.03.034_bib26","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/498652","article-title":"The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy","volume":"77","author":"Du","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"16","key":"10.1016\/j.xphs.2019.03.034_bib27","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/10.16.1639","article-title":"Enzyme therapy for lysosomal acid lipase deficiency in the mouse","volume":"10","author":"Du","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.xphs.2019.03.034_bib28","doi-asserted-by":"crossref","first-page":"29329","DOI":"10.1038\/srep29329","article-title":"Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris","volume":"6","author":"Rodriguez-Lopez","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2019.03.034_bib29","series-title":"Pichia Protocols","first-page":"107","article-title":"High cell-density fermentation","author":"Stratton","year":"1998"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.034_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nprot.2006.60","article-title":"Glycome mapping on DNA sequencing equipment","volume":"1","author":"Laroy","year":"2006","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.034_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nprot.2008.213","article-title":"Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology","volume":"4","author":"Jacobs","year":"2009","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.034_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2007.01.004","article-title":"Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase","volume":"91","author":"Tomatsu","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.xphs.2019.03.034_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.034_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-016-9981-6","article-title":"Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry","volume":"40","author":"Kubaski","year":"2017","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.03.034_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymgme.2016.09.005","article-title":"Glycosaminoglycans detection methods: applications of mass spectrometry","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.034_bib36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1590\/S1415-47572011005000022","article-title":"Expression and analysis of the glycosylation properties of recombinant human erythropoietin expressed in Pichia pastoris","volume":"34","author":"Teh","year":"2011","journal-title":"Genet Mol Biol"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.034_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-4157(87)90006-2","article-title":"Protein glycosylation in yeast","volume":"906","author":"Tanner","year":"1987","journal-title":"Biochim Biophys Acta"},{"issue":"41","key":"10.1016\/j.xphs.2019.03.034_bib38","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1002\/anie.200601645","article-title":"Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases","volume":"45","author":"Lehle","year":"2006","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.xphs.2019.03.034_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jbiotec.2017.04.028","article-title":"Therapeutic glycoprotein production in mammalian cells","volume":"251","author":"Lalonde","year":"2017","journal-title":"J\u00a0Biotechnol"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.034_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jbiotec.2012.06.038","article-title":"Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells","volume":"161","author":"Croset","year":"2012","journal-title":"J\u00a0Biotechnol"},{"issue":"12","key":"10.1016\/j.xphs.2019.03.034_bib41","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nbt.2427","article-title":"A\u00a0bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes","volume":"30","author":"Tiels","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.xphs.2019.03.034_bib42","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood.V93.9.2807.409k08_2807_2816","article-title":"A\u00a0comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease","volume":"93","author":"Friedman","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.034_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.23382","article-title":"Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease","volume":"88","author":"Ben Turkia","year":"2013","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.xphs.2019.03.034_bib44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ymgme.2008.04.009","article-title":"Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease","volume":"94","author":"McVie-Wylie","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.034_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","article-title":"Human plasma protein N-glycosylation","volume":"33","author":"Clerc","year":"2016","journal-title":"Glycoconj J"},{"issue":"5","key":"10.1016\/j.xphs.2019.03.034_bib46","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130081","article-title":"Glycosylation and functionality of recombinant beta-glucocerebrosidase from various production systems","volume":"33","author":"Tekoah","year":"2013","journal-title":"Biosci Rep"},{"key":"10.1016\/j.xphs.2019.03.034_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","article-title":"Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice","volume":"11","author":"Liu","year":"2005","journal-title":"Mol Ther"},{"issue":"21","key":"10.1016\/j.xphs.2019.03.034_bib48","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1016\/S0021-9258(18)63825-6","article-title":"Mannose 6-phosphate receptors and lysosomal enzyme targeting","volume":"264","author":"Dahms","year":"1989","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2019.03.034_bib49","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1038\/ncomms5321","article-title":"Lysosome sorting of beta-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor","volume":"5","author":"Zhao","year":"2014","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.034_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10545-015-9886-9","article-title":"Mannose receptor-mediated delivery of moss-made alpha-galactosidase A efficiently corrects enzyme deficiency in Fabry mice","volume":"39","author":"Shen","year":"2016","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"8","key":"10.1016\/j.xphs.2019.03.034_bib51","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/pbi.12529","article-title":"The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants","volume":"14","author":"Limkul","year":"2016","journal-title":"Plant Biotechnol J"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.034_bib52","first-page":"51","article-title":"[Investigation of redox homeostasis of liver in experimental and human studies]","volume":"74","author":"Hagymasi","year":"2004","journal-title":"Acta Pharm Hung"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.034_bib53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.07.012","article-title":"A\u00a0shortcut to the lysosome: the mannose-6-phosphate-independent pathway","volume":"107","author":"Coutinho","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.xphs.2019.03.034_bib54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of lysosomal proteins","volume":"1793","author":"Braulke","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2-3","key":"10.1016\/j.xphs.2019.03.034_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/rej.2009.0920","article-title":"New strategies for enzyme replacement therapy for lysosomal storage diseases","volume":"13","author":"Grubb","year":"2010","journal-title":"Rejuvenation Res"},{"issue":"Pt 10","key":"10.1016\/j.xphs.2019.03.034_bib56","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/jcs.112.10.1591","article-title":"Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific","volume":"112","author":"Dittmer","year":"1999","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.xphs.2019.03.034_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.bi.55.070186.001123","article-title":"Lysosomal enzymes and their receptors","volume":"55","author":"von Figura","year":"1986","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.034_bib58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0925-4439(98)00011-8","article-title":"Receptor mediated binding of two glycosylation forms of N-acetylgalactosamine-4-sulphatase","volume":"1406","author":"Fuller","year":"1998","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.xphs.2019.03.034_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02312548","article-title":"Uptake of lysosomal enzymes by human fibroblasts: lack of uptake of fungal or plant glycosidases in comparison with a mammalian enzyme","volume":"3","author":"Dooley","year":"1980","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"9","key":"10.1016\/j.xphs.2019.03.034_bib60","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/21678707.2017.1366900","article-title":"Enzyme replacement therapy with elosulfase alfa for mucopolysaccharidosis IVA (Morquio a syndrome): milestones and challenges","volume":"5","author":"Puckett","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"issue":"5","key":"10.1016\/j.xphs.2019.03.034_bib61","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood.V82.5.1402.1402","article-title":"Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase","volume":"82","author":"Richards","year":"1993","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.xphs.2019.03.034_bib62","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nbt.1484","article-title":"Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment","volume":"26","author":"Wang","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.xphs.2019.03.034_bib63","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/pr.2013.158","article-title":"Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients","volume":"74","author":"Vera","year":"2013","journal-title":"Pediatr Res"},{"issue":"22","key":"10.1016\/j.xphs.2019.03.034_bib64","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/hmg\/ddi364","article-title":"Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase","volume":"14","author":"Tomatsu","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.xphs.2019.03.034_bib65","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1194\/jlr.M700482-JLR200","article-title":"Wolman disease\/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice","volume":"49","author":"Du","year":"2008","journal-title":"J\u00a0Lipid Res"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.034_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2017.11.013","article-title":"RTB lectin-mediated delivery of lysosomal \u03b1-l-iduronidase mitigates disease manifestations systemically including the central nervous system","volume":"123","author":"Ou","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.xphs.2019.03.034_bib67","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.18632\/oncotarget.14314","article-title":"N-glycosylation converts non-glycoproteins into mannose receptor ligands and reveals antigen-specific T cell responses in\u00a0vivo","volume":"8","author":"Kreer","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xphs.2019.03.034_bib68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2016.10.006","article-title":"Antibodies that neutralize cellular uptake of elosulfase alfa are not associated with reduced efficacy or pharmacodynamic effect in individuals with Morquio A syndrome","volume":"440","author":"Melton","year":"2017","journal-title":"J\u00a0Immunol Methods"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919302187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919302187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:03:08Z","timestamp":1777420988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919302187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0022354919302187"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.03.034","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}